Ask-RX

What the Ask-RX Intake Looks Like

We walked through the Ask-RX funnel ourselves, and the headline finding is unusual: there is effectively no public clinical questionnaire. Ask-RX is a messaging-first physician-subscription service. The patient picks a plan, creates an account at checkout, and the entire medical assessment happens asynchronously inside the physician messaging portal after payment is authorized.

Ask-RX’s plan coverage language — “initial physician consultation via messaging, personalized titration protocol, unlimited physician messaging” — confirms that there is no separate pre-purchase questionnaire step. The entire clinical interview happens inside the physician messaging portal after the patient authorizes payment and creates their account. That is a legitimate async telehealth model, but it does mean the public funnel cannot catch contraindications or surface risk factors before the financial commitment is made. Patients should be prepared to answer a substantial clinical interview through the messaging portal in the first 24-48 hours after signup.

Ask-RX’s explicit “subscription covers physician care only — medication is paid separately, directly to the pharmacy” line is unusual in our catalog. Most platforms bundle physician review and medication into a single recurring charge; Ask-RX splits them. The subscription is $99 – $149 per month for unlimited physician messaging and ongoing titration, and the patient pays whatever pharmacy the provider prescribes at separately. The total monthly cost of treatment therefore depends on which medication and which pharmacy the provider chooses, and isn’t disclosed on the Ask-RX pricing page itself — patients should ask the physician up front what the expected pharmacy charge will be before authorizing the subscription.

The default cart label on the checkout page reads “Wegovy Tablet Visit”. That’s worth flagging: Wegovy (semaglutide) is FDA-approved only in an injectable formulation. An oral tablet labeled “Wegovy” does not exist as a Novo Nordisk product. The label on the cart may refer to a compounded oral semaglutide product or may simply be a mislabeled category name on the Ask-RX product catalog. Patients should confirm the exact formulation — compound, brand, injectable, or oral — with the physician in the first messaging exchange before continuing the subscription.

There is no BMI capture, no weight-loss goal, no medical history multi-select, no MTC or MEN-2 screen, no pancreatitis screen, no pregnancy screen, no eating disorder screen, no mental-health instrument, no substance-use screen, no current medications list, no allergy capture, no blood pressure or heart rate self-report, no drug interaction screen, no family history, no ID upload, and no phone OTP. Every safety question that the other platforms in our catalog surface as a structured gate is instead routed through the async physician messaging portal after checkout. That makes Ask-RX the lowest-friction intake we’ve audited, and also the one where the most clinical weight sits on the first messaging conversation with the provider.

Opens ask-rx.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.